EU patents approved for Quantum

Quantum is ValitaCell’s pioneering technology that powers a range of products including Valita®Titer. Innovation and the creation of ‘new to world’ technologies is central to ValitaCell’s culture. The creation and IP protection of our technologies is a key competitive advantage for our business and we are delighted that the EU has recognised the uniqueness of Quantum with an additional two patents.

The awarded patents are:

European patent No. 3170004. ‘A method of measuring antibody concentration in a sample’

European patent No. 3391049. ‘A method of determining the abundance of a target molecule in a sample’

Further Reading

Want to talk about our products?

Hi, I’m Eligio, Business Development Manager at ValitaCell. Fill in the form to the right and I’ll get in touch with you soon!

    I agree to receive marketing communication from ValitaCell by e-mail

    The controller of your personal data is ValitaCell. We process your personal data in order to respond to your questions and for sending marketing communication, if you agreed. You have the right to access data, the right to request rectification, deletion or limitation of their processing, data transfer, the right to object, as well as the right to lodge a complaint to the supervisory body. Full information about processing of personal data can be found in the Privacy Policy.

    Show More